Rank | Gene Set | Z-score |
---|---|---|
1 | axonemal dynein complex assembly (GO:0070286) | 7.90638408 |
2 | cilium movement (GO:0003341) | 7.49081858 |
3 | axoneme assembly (GO:0035082) | 6.19776332 |
4 | epithelial cilium movement (GO:0003351) | 5.84566707 |
5 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.81767076 |
6 | GTP biosynthetic process (GO:0006183) | 5.62515918 |
7 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.55036308 |
8 | ribosomal small subunit assembly (GO:0000028) | 5.42839978 |
9 | definitive hemopoiesis (GO:0060216) | 5.22102575 |
10 | UTP metabolic process (GO:0046051) | 4.96935203 |
11 | platelet dense granule organization (GO:0060155) | 4.93601787 |
12 | UTP biosynthetic process (GO:0006228) | 4.93150052 |
13 | motile cilium assembly (GO:0044458) | 4.75840099 |
14 | polyketide metabolic process (GO:0030638) | 4.68369751 |
15 | doxorubicin metabolic process (GO:0044598) | 4.68369751 |
16 | daunorubicin metabolic process (GO:0044597) | 4.68369751 |
17 | regulation of skeletal muscle contraction (GO:0014819) | 4.59822607 |
18 | response to peptidoglycan (GO:0032494) | 4.50468006 |
19 | protein carboxylation (GO:0018214) | 4.35416047 |
20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.35416047 |
21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.33165737 |
22 | nucleoside diphosphate phosphorylation (GO:0006165) | 4.32123655 |
23 | CTP metabolic process (GO:0046036) | 4.25353840 |
24 | CTP biosynthetic process (GO:0006241) | 4.25353840 |
25 | DNA deamination (GO:0045006) | 4.23206040 |
26 | guanosine-containing compound biosynthetic process (GO:1901070) | 4.14758638 |
27 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.12735281 |
28 | viral transcription (GO:0019083) | 4.11884635 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.07934192 |
30 | GDP-mannose metabolic process (GO:0019673) | 4.07669288 |
31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.06907958 |
32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04313953 |
33 | tolerance induction (GO:0002507) | 4.04292045 |
34 | detection of bacterium (GO:0016045) | 4.03063638 |
35 | detection of other organism (GO:0098543) | 4.02034943 |
36 | response to interferon-beta (GO:0035456) | 4.01304565 |
37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99558162 |
38 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.93313564 |
39 | ventricular system development (GO:0021591) | 3.91712674 |
40 | adenosine receptor signaling pathway (GO:0001973) | 3.90310756 |
41 | translational termination (GO:0006415) | 3.90091250 |
42 | negative regulation of interleukin-8 production (GO:0032717) | 3.89384885 |
43 | positive regulation of respiratory burst (GO:0060267) | 3.88727375 |
44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85917581 |
45 | negative regulation of cell killing (GO:0031342) | 3.85917581 |
46 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.83629678 |
47 | detection of molecule of bacterial origin (GO:0032490) | 3.79470170 |
48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77922287 |
49 | detection of external biotic stimulus (GO:0098581) | 3.76948932 |
50 | mitotic cell cycle arrest (GO:0071850) | 3.74623260 |
51 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.72307515 |
52 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.65937390 |
53 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65001203 |
54 | macrophage activation involved in immune response (GO:0002281) | 3.61413640 |
55 | cysteine metabolic process (GO:0006534) | 3.54313881 |
56 | mannose metabolic process (GO:0006013) | 3.53225053 |
57 | L-phenylalanine metabolic process (GO:0006558) | 3.48903257 |
58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.48903257 |
59 | positive regulation of heat generation (GO:0031652) | 3.48770951 |
60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48221225 |
61 | modulation by symbiont of host defense response (GO:0052031) | 3.48221225 |
62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48221225 |
63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48221225 |
64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48221225 |
65 | modulation by symbiont of host immune response (GO:0052553) | 3.48221225 |
66 | immunoglobulin mediated immune response (GO:0016064) | 3.47241132 |
67 | left/right axis specification (GO:0070986) | 3.47055459 |
68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.46639322 |
69 | L-phenylalanine catabolic process (GO:0006559) | 3.46639322 |
70 | regulation of tolerance induction (GO:0002643) | 3.44903582 |
71 | flavonoid metabolic process (GO:0009812) | 3.44740475 |
72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44667130 |
73 | regulation of synapse structural plasticity (GO:0051823) | 3.44503002 |
74 | response to type I interferon (GO:0034340) | 3.44488815 |
75 | cellular response to ATP (GO:0071318) | 3.43834407 |
76 | positive regulation of tolerance induction (GO:0002645) | 3.42209570 |
77 | neutrophil activation involved in immune response (GO:0002283) | 3.39462328 |
78 | aromatic amino acid family catabolic process (GO:0009074) | 3.38772474 |
79 | regulation of plasminogen activation (GO:0010755) | 3.37981058 |
80 | cellular response to type I interferon (GO:0071357) | 3.37933624 |
81 | type I interferon signaling pathway (GO:0060337) | 3.37933624 |
82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37364651 |
83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.35642925 |
84 | ribosomal small subunit biogenesis (GO:0042274) | 3.35552161 |
85 | translational elongation (GO:0006414) | 3.34175870 |
86 | S-adenosylmethionine metabolic process (GO:0046500) | 3.31325076 |
87 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.30660524 |
88 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.29943171 |
89 | tryptophan catabolic process (GO:0006569) | 3.27741716 |
90 | indole-containing compound catabolic process (GO:0042436) | 3.27741716 |
91 | indolalkylamine catabolic process (GO:0046218) | 3.27741716 |
92 | bile acid biosynthetic process (GO:0006699) | 3.27641403 |
93 | response to muramyl dipeptide (GO:0032495) | 3.27546063 |
94 | intraciliary transport (GO:0042073) | 3.24629545 |
95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24366411 |
96 | detection of biotic stimulus (GO:0009595) | 3.24326184 |
97 | transepithelial transport (GO:0070633) | 3.23851507 |
98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.22746172 |
99 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.22013114 |
100 | sulfur amino acid catabolic process (GO:0000098) | 3.17855333 |
101 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.17813009 |
102 | mature B cell differentiation involved in immune response (GO:0002313) | 3.17776235 |
103 | response to interferon-alpha (GO:0035455) | 3.16782776 |
104 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.16577805 |
105 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15976383 |
106 | secretory granule organization (GO:0033363) | 3.15532332 |
107 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.15127696 |
108 | regulation of germinal center formation (GO:0002634) | 3.13186560 |
109 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 3.12754292 |
110 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.10440770 |
111 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09929265 |
112 | cotranslational protein targeting to membrane (GO:0006613) | 3.09784684 |
113 | germinal center formation (GO:0002467) | 3.09373791 |
114 | negative regulation of interleukin-12 production (GO:0032695) | 3.09358176 |
115 | tryptophan metabolic process (GO:0006568) | 3.09331336 |
116 | protein targeting to ER (GO:0045047) | 3.07375727 |
117 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04412071 |
118 | regulation of respiratory burst (GO:0060263) | 3.03829872 |
119 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03553695 |
120 | imidazole-containing compound metabolic process (GO:0052803) | 3.03198068 |
121 | negative regulation of cell aging (GO:0090344) | 3.02518298 |
122 | lens fiber cell differentiation (GO:0070306) | 3.02476860 |
123 | negative regulation of innate immune response (GO:0045824) | 3.00319598 |
124 | respiratory chain complex IV assembly (GO:0008535) | 3.00172363 |
125 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00047438 |
126 | semaphorin-plexin signaling pathway (GO:0071526) | 2.96916826 |
127 | nucleoside diphosphate metabolic process (GO:0009132) | 2.93771658 |
128 | amino-acid betaine metabolic process (GO:0006577) | 2.93178736 |
129 | positive regulation of interferon-alpha production (GO:0032727) | 2.92856604 |
130 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.91792114 |
131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91776668 |
132 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91776668 |
133 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.91246810 |
134 | negative regulation of B cell mediated immunity (GO:0002713) | 2.91246810 |
135 | megakaryocyte development (GO:0035855) | 2.91146816 |
136 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90378936 |
137 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.90000320 |
138 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.89851730 |
139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89678936 |
140 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 2.89300733 |
141 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89116464 |
142 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.88958343 |
143 | regulation of cilium movement (GO:0003352) | 2.88379037 |
144 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88358699 |
145 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 2.87953737 |
146 | regulation of mast cell degranulation (GO:0043304) | 2.86961167 |
147 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.86608955 |
148 | myeloid cell activation involved in immune response (GO:0002275) | 2.86390144 |
149 | viral life cycle (GO:0019058) | 2.86145758 |
150 | reactive oxygen species biosynthetic process (GO:1903409) | 2.85952622 |
151 | glyoxylate metabolic process (GO:0046487) | 2.84214246 |
152 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.83891120 |
153 | regulation of antigen processing and presentation (GO:0002577) | 2.83765092 |
154 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.82693076 |
155 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.82254485 |
156 | alpha-linolenic acid metabolic process (GO:0036109) | 2.80630909 |
157 | regulation of interferon-alpha production (GO:0032647) | 2.80489781 |
158 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79922118 |
159 | coenzyme catabolic process (GO:0009109) | 2.79445200 |
160 | pseudouridine synthesis (GO:0001522) | 2.79186924 |
161 | regulation of interferon-beta production (GO:0032648) | 2.78868032 |
162 | response to nitrosative stress (GO:0051409) | 2.78850448 |
163 | response to xenobiotic stimulus (GO:0009410) | 2.78571308 |
164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.76401768 |
165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.75819769 |
166 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.75640562 |
167 | endosome to pigment granule transport (GO:0043485) | 2.75201473 |
168 | endosome to melanosome transport (GO:0035646) | 2.75201473 |
169 | lipoxygenase pathway (GO:0019372) | 2.73589016 |
170 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.73400825 |
171 | granulocyte differentiation (GO:0030851) | 2.72786299 |
172 | kynurenine metabolic process (GO:0070189) | 2.72727330 |
173 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72282652 |
174 | regulation of cholesterol esterification (GO:0010872) | 2.72191070 |
175 | heparin biosynthetic process (GO:0030210) | 2.70844598 |
176 | heparin metabolic process (GO:0030202) | 2.70844598 |
177 | NAD biosynthetic process (GO:0009435) | 2.69732955 |
178 | purinergic receptor signaling pathway (GO:0035587) | 2.69679691 |
179 | left/right pattern formation (GO:0060972) | 2.68726448 |
180 | cellular protein complex disassembly (GO:0043624) | 2.68676086 |
181 | AMP metabolic process (GO:0046033) | 2.67700198 |
182 | macrophage activation (GO:0042116) | 2.65782902 |
183 | leukocyte aggregation (GO:0070486) | 2.65193291 |
184 | primary alcohol catabolic process (GO:0034310) | 2.64444374 |
185 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.61296855 |
186 | nitrogen cycle metabolic process (GO:0071941) | 2.59976171 |
187 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59277283 |
188 | respiratory burst (GO:0045730) | 2.59165325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.72900918 |
2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.25704741 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.26258799 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04969681 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.36149708 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.25486628 |
7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.14044288 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.13165125 |
9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.12436978 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.10629096 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.06055216 |
12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.00965285 |
13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.00080792 |
14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.98942013 |
15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91233618 |
16 | P68_20966046_ChIP-Seq_HELA_Human | 2.58196205 |
17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.45681985 |
18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.44924916 |
19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39625731 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39605442 |
21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34677340 |
22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30664512 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23160148 |
24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.22320364 |
25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22027750 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21933101 |
27 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.20669667 |
28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20330488 |
29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19950827 |
30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14742200 |
31 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.09913495 |
32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08413840 |
33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06122143 |
34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.01522804 |
35 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.00877300 |
36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.98906575 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96963361 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96464481 |
39 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94520743 |
40 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.87317313 |
41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.87284694 |
42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86887090 |
43 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.85090170 |
44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85050946 |
45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82828070 |
46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82790501 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79642513 |
48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79421813 |
49 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.78911585 |
50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77413640 |
51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.77214176 |
52 | MYC_22102868_ChIP-Seq_BL_Human | 1.73855335 |
53 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.67861487 |
54 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.64380641 |
55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64186751 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63806034 |
57 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.62118633 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60279360 |
59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58036456 |
60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.57336793 |
61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56913057 |
62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55705801 |
63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55666509 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54997359 |
65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.52835649 |
66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52097801 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51483701 |
68 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50089158 |
69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.49763209 |
70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49158993 |
71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49117122 |
72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47127894 |
73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46848554 |
74 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44785190 |
75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43711108 |
76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43647286 |
77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.43349078 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42200160 |
79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41243446 |
80 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.40757764 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38981987 |
82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37646678 |
83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37177391 |
84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.36883020 |
85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36467944 |
86 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.35113640 |
87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.34753289 |
88 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.34245379 |
89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33590462 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31198316 |
91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30728838 |
92 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.30304052 |
93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.30207733 |
94 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30173839 |
95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.29845160 |
96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29843427 |
97 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.29588828 |
98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29547027 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29125209 |
100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29052807 |
101 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28728155 |
102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26206267 |
103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24550983 |
104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24113336 |
105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23716349 |
106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21554922 |
107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21239291 |
108 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21116141 |
109 | * MAF_26560356_Chip-Seq_TH1_Human | 1.20950259 |
110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20829697 |
111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20792465 |
112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.20392607 |
113 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19888210 |
114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19652923 |
115 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.18066160 |
116 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15888115 |
117 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15061066 |
118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14360991 |
119 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14136275 |
120 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13756942 |
121 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13686112 |
122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13554952 |
123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13447320 |
124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13353498 |
125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12279704 |
126 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11866349 |
127 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08372995 |
128 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07986793 |
129 | MYB_26560356_Chip-Seq_TH1_Human | 1.07941696 |
130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07317486 |
131 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06515787 |
132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06002704 |
133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05745478 |
134 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05130739 |
135 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03310738 |
136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02557278 |
137 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02543525 |
138 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01833797 |
139 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.99959685 |
140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.98883933 |
141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98809511 |
142 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98506580 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97828337 |
144 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96864165 |
145 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95519922 |
146 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95299441 |
147 | * MYB_26560356_Chip-Seq_TH2_Human | 0.94210864 |
148 | P300_27268052_Chip-Seq_Bcells_Human | 0.93793318 |
149 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93263244 |
150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92659891 |
151 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.90312045 |
152 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89928342 |
153 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89757869 |
154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89441102 |
155 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88814596 |
156 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88246461 |
157 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87574214 |
158 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87166796 |
159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85566311 |
160 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85357851 |
161 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83973654 |
162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83853501 |
163 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83763837 |
164 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82482023 |
165 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81519704 |
166 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80894498 |
167 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80041790 |
168 | MAF_26560356_Chip-Seq_TH2_Human | 0.79838441 |
169 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.79491593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.65056757 |
2 | MP0005360_urolithiasis | 4.20672132 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.06879658 |
4 | MP0005365_abnormal_bile_salt | 3.93990465 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86622255 |
6 | MP0003303_peritoneal_inflammation | 3.68429279 |
7 | MP0003136_yellow_coat_color | 3.27606300 |
8 | MP0005171_absent_coat_pigmentation | 3.25062025 |
9 | MP0006082_CNS_inflammation | 2.78648125 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.67809712 |
11 | MP0009697_abnormal_copulation | 2.64113684 |
12 | MP0005075_abnormal_melanosome_morpholog | 2.58589370 |
13 | MP0009379_abnormal_foot_pigmentation | 2.54931596 |
14 | MP0004147_increased_porphyrin_level | 2.51849587 |
15 | MP0002396_abnormal_hematopoietic_system | 2.41813848 |
16 | MP0010329_abnormal_lipoprotein_level | 2.34173888 |
17 | MP0005387_immune_system_phenotype | 2.33404753 |
18 | MP0003724_increased_susceptibility_to | 2.28970608 |
19 | MP0005058_abnormal_lysosome_morphology | 2.26998856 |
20 | MP0003453_abnormal_keratinocyte_physiol | 2.12780750 |
21 | MP0003252_abnormal_bile_duct | 2.12302699 |
22 | MP0005174_abnormal_tail_pigmentation | 2.11650107 |
23 | MP0000685_abnormal_immune_system | 2.07461567 |
24 | MP0005464_abnormal_platelet_physiology | 2.02007810 |
25 | MP0004808_abnormal_hematopoietic_stem | 2.00277002 |
26 | MP0003011_delayed_dark_adaptation | 1.95990544 |
27 | MP0003172_abnormal_lysosome_physiology | 1.92150129 |
28 | MP0001764_abnormal_homeostasis | 1.85739497 |
29 | MP0001666_abnormal_nutrient_absorption | 1.82913672 |
30 | MP0005000_abnormal_immune_tolerance | 1.80412212 |
31 | MP0001545_abnormal_hematopoietic_system | 1.79067202 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.79067202 |
33 | MP0002277_abnormal_respiratory_mucosa | 1.79042121 |
34 | MP0003878_abnormal_ear_physiology | 1.67306551 |
35 | MP0005377_hearing/vestibular/ear_phenot | 1.67306551 |
36 | MP0001873_stomach_inflammation | 1.66913011 |
37 | MP0002095_abnormal_skin_pigmentation | 1.65861984 |
38 | MP0009785_altered_susceptibility_to | 1.61225098 |
39 | MP0009278_abnormal_bone_marrow | 1.60975001 |
40 | MP0002132_abnormal_respiratory_system | 1.59985267 |
41 | MP0003656_abnormal_erythrocyte_physiolo | 1.55113081 |
42 | MP0002254_reproductive_system_inflammat | 1.55046650 |
43 | MP0003868_abnormal_feces_composition | 1.55046240 |
44 | MP0003943_abnormal_hepatobiliary_system | 1.54874296 |
45 | MP0005423_abnormal_somatic_nervous | 1.53543390 |
46 | MP0005409_darkened_coat_color | 1.53457003 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.53071461 |
48 | MP0000751_myopathy | 1.48561908 |
49 | MP0003866_abnormal_defecation | 1.44062082 |
50 | MP0004947_skin_inflammation | 1.42562631 |
51 | MP0005319_abnormal_enzyme/_coenzyme | 1.42372892 |
52 | MP0001533_abnormal_skeleton_physiology | 1.42285001 |
53 | MP0008004_abnormal_stomach_pH | 1.40250182 |
54 | MP0000858_altered_metastatic_potential | 1.39619968 |
55 | MP0004019_abnormal_vitamin_homeostasis | 1.38392940 |
56 | MP0004381_abnormal_hair_follicle | 1.38374798 |
57 | MP0001986_abnormal_taste_sensitivity | 1.37332963 |
58 | MP0005330_cardiomyopathy | 1.37285389 |
59 | MP0001835_abnormal_antigen_presentation | 1.37167352 |
60 | MP0005332_abnormal_amino_acid | 1.36767209 |
61 | MP0006054_spinal_hemorrhage | 1.36671152 |
62 | MP0005025_abnormal_response_to | 1.36561084 |
63 | MP0000465_gastrointestinal_hemorrhage | 1.34526097 |
64 | MP0001853_heart_inflammation | 1.33938224 |
65 | MP0005410_abnormal_fertilization | 1.33156958 |
66 | MP0002653_abnormal_ependyma_morphology | 1.31556584 |
67 | MP0003763_abnormal_thymus_physiology | 1.30729653 |
68 | MP0006036_abnormal_mitochondrial_physio | 1.30311246 |
69 | MP0002249_abnormal_larynx_morphology | 1.29370277 |
70 | MP0004043_abnormal_pH_regulation | 1.29064368 |
71 | MP0009840_abnormal_foam_cell | 1.27589707 |
72 | MP0003186_abnormal_redox_activity | 1.25875280 |
73 | MP0004510_myositis | 1.25124947 |
74 | MP0010155_abnormal_intestine_physiology | 1.24926279 |
75 | MP0001756_abnormal_urination | 1.24679527 |
76 | MP0000609_abnormal_liver_physiology | 1.23528184 |
77 | MP0005083_abnormal_biliary_tract | 1.23344363 |
78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23023934 |
79 | MP0001765_abnormal_ion_homeostasis | 1.22844021 |
80 | MP0005084_abnormal_gallbladder_morpholo | 1.21079481 |
81 | MP0005671_abnormal_response_to | 1.20270144 |
82 | MP0003448_altered_tumor_morphology | 1.20074531 |
83 | MP0002928_abnormal_bile_duct | 1.19113835 |
84 | MP0002118_abnormal_lipid_homeostasis | 1.16697462 |
85 | MP0008469_abnormal_protein_level | 1.16492532 |
86 | MP0006292_abnormal_olfactory_placode | 1.13420842 |
87 | MP0001663_abnormal_digestive_system | 1.12491716 |
88 | MP0008995_early_reproductive_senescence | 1.10346319 |
89 | MP0009333_abnormal_splenocyte_physiolog | 1.09317833 |
90 | MP0010368_abnormal_lymphatic_system | 1.07704750 |
91 | MP0000750_abnormal_muscle_regeneration | 1.07633560 |
92 | MP0003436_decreased_susceptibility_to | 1.07400864 |
93 | MP0002933_joint_inflammation | 1.06521987 |
94 | MP0005310_abnormal_salivary_gland | 1.06310868 |
95 | MP0005076_abnormal_cell_differentiation | 1.03815742 |
96 | MP0004130_abnormal_muscle_cell | 1.02502104 |
97 | MP0005636_abnormal_mineral_homeostasis | 1.02090784 |
98 | MP0005166_decreased_susceptibility_to | 1.01276542 |
99 | MP0001188_hyperpigmentation | 1.00285079 |
100 | MP0009763_increased_sensitivity_to | 0.99479506 |
101 | MP0000689_abnormal_spleen_morphology | 0.97420105 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.97378396 |
103 | MP0009643_abnormal_urine_homeostasis | 0.95853859 |
104 | MP0001800_abnormal_humoral_immune | 0.95541519 |
105 | MP0000598_abnormal_liver_morphology | 0.95484905 |
106 | MP0001661_extended_life_span | 0.95098001 |
107 | MP0003300_gastrointestinal_ulcer | 0.94577831 |
108 | MP0001502_abnormal_circadian_rhythm | 0.94268963 |
109 | MP0009764_decreased_sensitivity_to | 0.93765599 |
110 | MP0001958_emphysema | 0.93127903 |
111 | MP0000490_abnormal_crypts_of | 0.92282909 |
112 | MP0002398_abnormal_bone_marrow | 0.92027314 |
113 | MP0002723_abnormal_immune_serum | 0.90920122 |
114 | MP0005023_abnormal_wound_healing | 0.90609117 |
115 | MP0005647_abnormal_sex_gland | 0.90164926 |
116 | MP0002722_abnormal_immune_system | 0.90003628 |
117 | MP0003705_abnormal_hypodermis_morpholog | 0.89446019 |
118 | MP0002998_abnormal_bone_remodeling | 0.88870393 |
119 | MP0001845_abnormal_inflammatory_respons | 0.88606153 |
120 | MP0002405_respiratory_system_inflammati | 0.87795354 |
121 | MP0002160_abnormal_reproductive_system | 0.87679800 |
122 | MP0000015_abnormal_ear_pigmentation | 0.84372636 |
123 | MP0004782_abnormal_surfactant_physiolog | 0.84102416 |
124 | MP0008260_abnormal_autophagy | 0.83366598 |
125 | MP0002148_abnormal_hypersensitivity_rea | 0.83275273 |
126 | MP0002136_abnormal_kidney_physiology | 0.83021112 |
127 | MP0003638_abnormal_response/metabolism_ | 0.82556471 |
128 | MP0001879_abnormal_lymphatic_vessel | 0.81701559 |
129 | MP0003091_abnormal_cell_migration | 0.81580422 |
130 | MP0009642_abnormal_blood_homeostasis | 0.80655829 |
131 | MP0002429_abnormal_blood_cell | 0.80219782 |
132 | MP0000470_abnormal_stomach_morphology | 0.79594606 |
133 | MP0000716_abnormal_immune_system | 0.79133643 |
134 | MP0001664_abnormal_digestion | 0.77884063 |
135 | MP0005646_abnormal_pituitary_gland | 0.77861793 |
136 | MP0003075_altered_response_to | 0.76523988 |
137 | MP0002419_abnormal_innate_immunity | 0.76476887 |
138 | MP0002452_abnormal_antigen_presenting | 0.76188068 |
139 | MP0005167_abnormal_blood-brain_barrier | 0.76132384 |
140 | MP0002420_abnormal_adaptive_immunity | 0.76060245 |
141 | MP0001819_abnormal_immune_cell | 0.73367768 |
142 | MP0000747_muscle_weakness | 0.72642637 |
143 | MP0001929_abnormal_gametogenesis | 0.72609516 |
144 | MP0000343_altered_response_to | 0.71715622 |
145 | MP0004883_abnormal_blood_vessel | 0.70165464 |
146 | MP0002166_altered_tumor_susceptibility | 0.69057925 |
147 | MP0003698_abnormal_male_reproductive | 0.68854158 |
148 | MP0001790_abnormal_immune_system | 0.65154366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.25006023 |
2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 7.87421997 |
3 | Abnormal ciliary motility (HP:0012262) | 7.66187175 |
4 | Rhinitis (HP:0012384) | 7.01655002 |
5 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.32404378 |
6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.32404378 |
7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.42744722 |
8 | Absent/shortened dynein arms (HP:0200106) | 5.42744722 |
9 | Nasal polyposis (HP:0100582) | 4.91582409 |
10 | Abnormality of the nasal mucosa (HP:0000433) | 4.80846572 |
11 | Chronic bronchitis (HP:0004469) | 4.73591911 |
12 | Bronchiectasis (HP:0002110) | 4.58420453 |
13 | Dyschromatopsia (HP:0007641) | 4.41852396 |
14 | Hemorrhage of the eye (HP:0011885) | 4.30098935 |
15 | Testicular atrophy (HP:0000029) | 4.29567752 |
16 | Mesangial abnormality (HP:0001966) | 4.01696863 |
17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56383045 |
18 | Rib fusion (HP:0000902) | 3.50086884 |
19 | Thin bony cortex (HP:0002753) | 3.43531529 |
20 | Bronchitis (HP:0012387) | 3.28906598 |
21 | Choroideremia (HP:0001139) | 3.26549397 |
22 | Chronic sinusitis (HP:0011109) | 3.24587938 |
23 | Popliteal pterygium (HP:0009756) | 3.23507106 |
24 | True hermaphroditism (HP:0010459) | 3.18528443 |
25 | Chronic hepatic failure (HP:0100626) | 3.17116690 |
26 | Intrahepatic cholestasis (HP:0001406) | 3.16796464 |
27 | Pancreatic fibrosis (HP:0100732) | 3.16001435 |
28 | Attenuation of retinal blood vessels (HP:0007843) | 3.15920437 |
29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.09473238 |
30 | Aplastic anemia (HP:0001915) | 3.04722995 |
31 | Facial diplegia (HP:0001349) | 3.02871516 |
32 | Decreased central vision (HP:0007663) | 3.01348645 |
33 | Eczematoid dermatitis (HP:0000976) | 2.98229406 |
34 | Recurrent sinusitis (HP:0011108) | 2.93255605 |
35 | Fetal akinesia sequence (HP:0001989) | 2.90801439 |
36 | Thrombocytosis (HP:0001894) | 2.89851360 |
37 | Molar tooth sign on MRI (HP:0002419) | 2.85997503 |
38 | Abnormality of midbrain morphology (HP:0002418) | 2.85997503 |
39 | Abnormal number of erythroid precursors (HP:0012131) | 2.85804889 |
40 | Prolonged partial thromboplastin time (HP:0003645) | 2.84755164 |
41 | Male infertility (HP:0003251) | 2.84748816 |
42 | Aplasia of the musculature (HP:0100854) | 2.84625340 |
43 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.82757633 |
44 | Prolonged bleeding time (HP:0003010) | 2.78815633 |
45 | Annular pancreas (HP:0001734) | 2.77862169 |
46 | Pancreatic cysts (HP:0001737) | 2.77620521 |
47 | Akinesia (HP:0002304) | 2.77175899 |
48 | Myositis (HP:0100614) | 2.77084261 |
49 | Recurrent abscess formation (HP:0002722) | 2.74385924 |
50 | Recurrent bacterial skin infections (HP:0005406) | 2.72307640 |
51 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.68300773 |
52 | Malnutrition (HP:0004395) | 2.66644353 |
53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65625903 |
54 | Spontaneous abortion (HP:0005268) | 2.64010709 |
55 | Hypobetalipoproteinemia (HP:0003563) | 2.60315414 |
56 | Vaginal fistula (HP:0004320) | 2.58999911 |
57 | Epistaxis (HP:0000421) | 2.56477569 |
58 | Abnormality of macrophages (HP:0004311) | 2.53028629 |
59 | Bile duct proliferation (HP:0001408) | 2.52825791 |
60 | Abnormal biliary tract physiology (HP:0012439) | 2.52825791 |
61 | Ulnar bowing (HP:0003031) | 2.52261610 |
62 | Tubulointerstitial nephritis (HP:0001970) | 2.46080027 |
63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46032484 |
64 | Gastrointestinal infarctions (HP:0005244) | 2.45959524 |
65 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.44989150 |
66 | Rectovaginal fistula (HP:0000143) | 2.44451594 |
67 | Rectal fistula (HP:0100590) | 2.44451594 |
68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44234975 |
69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44234975 |
70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44234975 |
71 | Renal Fanconi syndrome (HP:0001994) | 2.43929478 |
72 | Median cleft lip (HP:0000161) | 2.42886432 |
73 | Petechiae (HP:0000967) | 2.38826214 |
74 | Poikiloderma (HP:0001029) | 2.37339151 |
75 | Intestinal fistula (HP:0100819) | 2.35442693 |
76 | Oral leukoplakia (HP:0002745) | 2.35432006 |
77 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34576351 |
78 | Recurrent bronchitis (HP:0002837) | 2.32449724 |
79 | Abnormal albumin level (HP:0012116) | 2.30626892 |
80 | Hypoalbuminemia (HP:0003073) | 2.30626892 |
81 | Reduced antithrombin III activity (HP:0001976) | 2.29212048 |
82 | Atrioventricular block (HP:0001678) | 2.29047796 |
83 | Mucopolysacchariduria (HP:0008155) | 2.28814877 |
84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28814877 |
85 | Atelectasis (HP:0100750) | 2.28412374 |
86 | Infertility (HP:0000789) | 2.27054944 |
87 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.26043229 |
88 | Orchitis (HP:0100796) | 2.26038764 |
89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23466291 |
90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23466291 |
91 | IgM deficiency (HP:0002850) | 2.23249541 |
92 | Neoplasm of head and neck (HP:0012288) | 2.21411588 |
93 | Esophageal neoplasm (HP:0100751) | 2.21411588 |
94 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.21096030 |
95 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.21096030 |
96 | Purpura (HP:0000979) | 2.20461804 |
97 | Xanthomatosis (HP:0000991) | 2.20070905 |
98 | Joint hemorrhage (HP:0005261) | 2.19030460 |
99 | Zonular cataract (HP:0010920) | 2.18511585 |
100 | Abnormality of the costochondral junction (HP:0000919) | 2.17227448 |
101 | Congenital hepatic fibrosis (HP:0002612) | 2.16950086 |
102 | Lipid accumulation in hepatocytes (HP:0006561) | 2.16572436 |
103 | Impaired platelet aggregation (HP:0003540) | 2.16424736 |
104 | Abnormal platelet function (HP:0011869) | 2.16424736 |
105 | Joint stiffness (HP:0001387) | 2.15650310 |
106 | Menorrhagia (HP:0000132) | 2.14690078 |
107 | Gingival bleeding (HP:0000225) | 2.14686922 |
108 | Supernumerary spleens (HP:0009799) | 2.14521159 |
109 | Occipital encephalocele (HP:0002085) | 2.12253368 |
110 | Recurrent otitis media (HP:0000403) | 2.11993409 |
111 | Pancytopenia (HP:0001876) | 2.10983618 |
112 | Deep venous thrombosis (HP:0002625) | 2.08697425 |
113 | Delayed epiphyseal ossification (HP:0002663) | 2.07788969 |
114 | Recurrent skin infections (HP:0001581) | 2.06645672 |
115 | Retrobulbar optic neuritis (HP:0100654) | 2.06488656 |
116 | Optic neuritis (HP:0100653) | 2.06488656 |
117 | Nephronophthisis (HP:0000090) | 2.05526855 |
118 | Turricephaly (HP:0000262) | 2.04845259 |
119 | Exertional dyspnea (HP:0002875) | 2.04406863 |
120 | Ketosis (HP:0001946) | 2.03974663 |
121 | Cystic liver disease (HP:0006706) | 2.03451960 |
122 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.00812785 |
123 | Recurrent fungal infections (HP:0002841) | 2.00666556 |
124 | Hyperbilirubinemia (HP:0002904) | 1.98327283 |
125 | Hyperammonemia (HP:0001987) | 1.97603766 |
126 | Widely patent fontanelles and sutures (HP:0004492) | 1.97215425 |
127 | Hyperglycinemia (HP:0002154) | 1.97058391 |
128 | Hyperlipoproteinemia (HP:0010980) | 1.96869028 |
129 | Microcytic anemia (HP:0001935) | 1.96449851 |
130 | Cheilitis (HP:0100825) | 1.94392401 |
131 | Reticulocytopenia (HP:0001896) | 1.94353102 |
132 | Macular degeneration (HP:0000608) | 1.92696110 |
133 | Increased muscle lipid content (HP:0009058) | 1.91998965 |
134 | Type II lissencephaly (HP:0007260) | 1.91441984 |
135 | Colitis (HP:0002583) | 1.91128447 |
136 | Facial hemangioma (HP:0000329) | 1.89629860 |
137 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89352352 |
138 | Respiratory difficulties (HP:0002880) | 1.89174135 |
139 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88270159 |
140 | Fat malabsorption (HP:0002630) | 1.87138563 |
141 | Abnormality of glycine metabolism (HP:0010895) | 1.86495285 |
142 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86495285 |
143 | Obstructive lung disease (HP:0006536) | 1.86308065 |
144 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86308065 |
145 | Systemic lupus erythematosus (HP:0002725) | 1.85826467 |
146 | 11 pairs of ribs (HP:0000878) | 1.84818452 |
147 | Decreased circulating renin level (HP:0003351) | 1.84816978 |
148 | Squamous cell carcinoma (HP:0002860) | 1.84490575 |
149 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.82967285 |
150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81322211 |
151 | Dysostosis multiplex (HP:0000943) | 1.81206140 |
152 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80527842 |
153 | Abnormality of the axillary hair (HP:0100134) | 1.79007368 |
154 | Abnormality of secondary sexual hair (HP:0009888) | 1.79007368 |
155 | Dicarboxylic aciduria (HP:0003215) | 1.78440072 |
156 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78440072 |
157 | Hyperglycinuria (HP:0003108) | 1.77357100 |
158 | Enlarged epiphyses (HP:0010580) | 1.76109399 |
159 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75758874 |
160 | Postaxial foot polydactyly (HP:0001830) | 1.75253237 |
161 | Hepatic necrosis (HP:0002605) | 1.74662265 |
162 | Delayed CNS myelination (HP:0002188) | 1.71630695 |
163 | Hepatocellular necrosis (HP:0001404) | 1.71518201 |
164 | Chronic otitis media (HP:0000389) | 1.69211877 |
165 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69197645 |
166 | Portal hypertension (HP:0001409) | 1.68496509 |
167 | Asplenia (HP:0001746) | 1.68253671 |
168 | Acute myeloid leukemia (HP:0004808) | 1.67387198 |
169 | Metabolic acidosis (HP:0001942) | 1.67300654 |
170 | Abnormal spermatogenesis (HP:0008669) | 1.66300989 |
171 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.65852978 |
172 | Increased intramyocellular lipid droplets (HP:0012240) | 1.63471755 |
173 | Hypolipoproteinemia (HP:0010981) | 1.62631003 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 5.71067721 |
2 | MUSK | 3.78861864 |
3 | BLK | 3.43567173 |
4 | STK16 | 3.17418699 |
5 | RIPK4 | 2.81679367 |
6 | CSK | 2.64558183 |
7 | TGFBR1 | 2.55346166 |
8 | BCKDK | 2.53729508 |
9 | KIT | 2.53422299 |
10 | PIK3CG | 2.51224719 |
11 | FLT3 | 2.44220592 |
12 | WEE1 | 2.28872779 |
13 | TNIK | 2.23255015 |
14 | VRK1 | 2.17176819 |
15 | TGFBR2 | 2.14548871 |
16 | PIM2 | 2.08877007 |
17 | TEC | 1.96406175 |
18 | TIE1 | 1.94171987 |
19 | TYK2 | 1.86891799 |
20 | BTK | 1.76743670 |
21 | MAP3K3 | 1.71956656 |
22 | MAP2K6 | 1.71006802 |
23 | NLK | 1.68656497 |
24 | MAP2K3 | 1.66552431 |
25 | CAMKK2 | 1.66480049 |
26 | TRIB3 | 1.64943835 |
27 | PRKG2 | 1.64674895 |
28 | TLK1 | 1.63258963 |
29 | NME2 | 1.62133947 |
30 | MAPKAPK5 | 1.57240395 |
31 | MAP3K12 | 1.46868129 |
32 | MAP4K1 | 1.44623448 |
33 | MATK | 1.43644535 |
34 | MAP2K7 | 1.40392237 |
35 | EPHA2 | 1.36028838 |
36 | EEF2K | 1.34939059 |
37 | ADRBK2 | 1.34398268 |
38 | CDK8 | 1.30096969 |
39 | MAP3K11 | 1.27041941 |
40 | TNK2 | 1.25649347 |
41 | GRK1 | 1.24346221 |
42 | CSF1R | 1.24183690 |
43 | WNK4 | 1.23682068 |
44 | CDK19 | 1.22616381 |
45 | SIK2 | 1.21208000 |
46 | PDPK1 | 1.19301634 |
47 | MAP3K14 | 1.18176763 |
48 | RPS6KB2 | 1.15776006 |
49 | SIK1 | 1.14971695 |
50 | DYRK3 | 1.14963649 |
51 | JAK3 | 1.13264238 |
52 | ACVR1B | 1.12943625 |
53 | BRSK2 | 1.11148435 |
54 | TESK2 | 1.11133666 |
55 | SMG1 | 1.07689503 |
56 | IRAK1 | 1.06768940 |
57 | MAP2K2 | 1.06662984 |
58 | PRKD2 | 1.05640716 |
59 | KDR | 1.05120652 |
60 | IRAK3 | 1.04902315 |
61 | TAOK1 | 1.03208517 |
62 | PNCK | 1.00972421 |
63 | PRPF4B | 0.99751514 |
64 | FES | 0.99090860 |
65 | MAP3K10 | 0.96151013 |
66 | LRRK2 | 0.95457451 |
67 | MYLK | 0.95428496 |
68 | MARK2 | 0.95334460 |
69 | MKNK1 | 0.90007639 |
70 | CDC42BPA | 0.89834207 |
71 | SIK3 | 0.87547578 |
72 | PINK1 | 0.87348652 |
73 | TAOK3 | 0.86063343 |
74 | DYRK1B | 0.85462626 |
75 | CSNK1G1 | 0.82727974 |
76 | IRAK2 | 0.82365342 |
77 | BMX | 0.79548122 |
78 | PAK2 | 0.79463397 |
79 | MAP3K1 | 0.79435236 |
80 | HCK | 0.77899906 |
81 | TBK1 | 0.77813212 |
82 | CAMK1 | 0.77388067 |
83 | MAP3K13 | 0.75680807 |
84 | FGR | 0.75104017 |
85 | RIPK1 | 0.74570343 |
86 | ERN1 | 0.74097504 |
87 | EPHA3 | 0.71787955 |
88 | MAP3K6 | 0.71011565 |
89 | MAPK4 | 0.68310237 |
90 | JAK1 | 0.66190457 |
91 | FGFR4 | 0.64912999 |
92 | PTK6 | 0.61983349 |
93 | SYK | 0.60967088 |
94 | PRKD1 | 0.58794897 |
95 | IKBKE | 0.58670517 |
96 | MST1R | 0.58445785 |
97 | CSNK1G3 | 0.57573071 |
98 | RPS6KA2 | 0.57153959 |
99 | LCK | 0.56303334 |
100 | JAK2 | 0.55931828 |
101 | ADRBK1 | 0.55456231 |
102 | NEK9 | 0.55371201 |
103 | CDK6 | 0.55191359 |
104 | LYN | 0.55020902 |
105 | TAOK2 | 0.54773183 |
106 | GRK6 | 0.53283282 |
107 | PDK1 | 0.52430526 |
108 | IRAK4 | 0.52100832 |
109 | CCNB1 | 0.51851210 |
110 | IKBKB | 0.51698538 |
111 | PDK3 | 0.51010952 |
112 | PDK4 | 0.51010952 |
113 | PAK1 | 0.50479099 |
114 | CDK3 | 0.50103366 |
115 | STK10 | 0.49888162 |
116 | MAP2K4 | 0.49742224 |
117 | TXK | 0.49577671 |
118 | MAPK11 | 0.48015026 |
119 | RPS6KA5 | 0.47289366 |
120 | MKNK2 | 0.46120111 |
121 | ARAF | 0.45535484 |
122 | MAP3K2 | 0.44890716 |
123 | EPHB1 | 0.44559778 |
124 | PRKCD | 0.43966628 |
125 | MAPKAPK3 | 0.43621205 |
126 | CDK4 | 0.43021462 |
127 | YES1 | 0.42736707 |
128 | CHUK | 0.42681034 |
129 | MAPK7 | 0.42337942 |
130 | MAPK12 | 0.41535068 |
131 | RPS6KA6 | 0.41504686 |
132 | STK11 | 0.41480151 |
133 | PTK2B | 0.41114794 |
134 | MST4 | 0.40713616 |
135 | HIPK2 | 0.40118902 |
136 | STK38 | 0.39670275 |
137 | ICK | 0.39498499 |
138 | RPS6KL1 | 0.38326246 |
139 | RPS6KC1 | 0.38326246 |
140 | PRKCQ | 0.36341752 |
141 | MAP3K7 | 0.35686881 |
142 | NEK2 | 0.35608431 |
143 | GRK7 | 0.35232889 |
144 | MAPK3 | 0.34840184 |
145 | PIM1 | 0.34496136 |
146 | PRKAA2 | 0.34341972 |
147 | SRPK1 | 0.34323721 |
148 | ZAP70 | 0.33718379 |
149 | FYN | 0.33169587 |
150 | DAPK1 | 0.30510058 |
151 | CASK | 0.30253785 |
152 | MARK3 | 0.29520563 |
153 | ATR | 0.28881426 |
154 | NME1 | 0.28792508 |
155 | RAF1 | 0.27143579 |
156 | LMTK2 | 0.26329524 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.77412867 |
2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.43973175 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.21476061 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.94522285 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.94039786 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75126897 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51600670 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45811717 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.42766827 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35725449 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16724813 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 2.13704784 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12097278 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05264439 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03006038 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01811147 |
17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.01228487 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00959246 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98193051 |
20 | DNA replication_Homo sapiens_hsa03030 | 1.94687388 |
21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.89113548 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88679650 |
23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88356600 |
24 | Peroxisome_Homo sapiens_hsa04146 | 1.86376314 |
25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.85758746 |
26 | Mismatch repair_Homo sapiens_hsa03430 | 1.82610546 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78797147 |
28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.78643364 |
29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77791010 |
30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.76746699 |
31 | Tuberculosis_Homo sapiens_hsa05152 | 1.70458407 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70382295 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68698784 |
34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68679201 |
35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.68667048 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.65378214 |
37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65007044 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65000358 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.63895634 |
40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63429891 |
41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63316586 |
42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59929929 |
43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59123250 |
44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.57136495 |
45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56829371 |
46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54430956 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53823725 |
48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53152411 |
49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50538860 |
50 | Asthma_Homo sapiens_hsa05310 | 1.50167639 |
51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46864971 |
52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45558574 |
53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42261519 |
54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41670558 |
55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38283700 |
56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28799795 |
57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28398903 |
58 | Malaria_Homo sapiens_hsa05144 | 1.27751392 |
59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27437723 |
60 | Influenza A_Homo sapiens_hsa05164 | 1.27105059 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 1.25239419 |
62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24100485 |
63 | Pertussis_Homo sapiens_hsa05133 | 1.23378338 |
64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19708067 |
65 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19561283 |
66 | ABC transporters_Homo sapiens_hsa02010 | 1.18117082 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17595846 |
68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15731592 |
69 | Purine metabolism_Homo sapiens_hsa00230 | 1.13576075 |
70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12795146 |
71 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10791906 |
72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10380880 |
73 | Homologous recombination_Homo sapiens_hsa03440 | 1.06954252 |
74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05995028 |
75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04870183 |
76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03786704 |
77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03541785 |
78 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03261337 |
79 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03166339 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03012564 |
81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99013711 |
82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98618228 |
83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98106187 |
84 | Measles_Homo sapiens_hsa05162 | 0.97749952 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97357935 |
86 | Base excision repair_Homo sapiens_hsa03410 | 0.97219402 |
87 | Phagosome_Homo sapiens_hsa04145 | 0.94037425 |
88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93548859 |
89 | Bile secretion_Homo sapiens_hsa04976 | 0.91487618 |
90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91059526 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90640128 |
92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90464453 |
93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89417335 |
94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89127970 |
95 | Legionellosis_Homo sapiens_hsa05134 | 0.84144471 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83454545 |
97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82274784 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82102259 |
99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81486566 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80579172 |
101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79372932 |
102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79150653 |
103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78059740 |
104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76037445 |
105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76021688 |
106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75551658 |
107 | Salmonella infection_Homo sapiens_hsa05132 | 0.73830881 |
108 | Endocytosis_Homo sapiens_hsa04144 | 0.73651602 |
109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71812397 |
110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71339403 |
111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70470374 |
112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70238956 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69064142 |
114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68527477 |
115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67281356 |
116 | Apoptosis_Homo sapiens_hsa04210 | 0.62654086 |
117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62326087 |
118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62178055 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61735031 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61482299 |
121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61335423 |
122 | Insulin resistance_Homo sapiens_hsa04931 | 0.60645231 |
123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59048904 |
124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57435700 |
125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55266912 |
126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55192616 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55047618 |
128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53312741 |
129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52801963 |
130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52600876 |
131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50460544 |
132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49533101 |
133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49178613 |
134 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48136726 |
135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47505545 |
136 | Hepatitis B_Homo sapiens_hsa05161 | 0.47161396 |
137 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46114579 |
138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45077977 |
139 | Bladder cancer_Homo sapiens_hsa05219 | 0.44969797 |
140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44745363 |
141 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43547385 |
142 | RNA degradation_Homo sapiens_hsa03018 | 0.42039261 |
143 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41883925 |
144 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40720893 |
145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40411190 |
146 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39671074 |
147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38916457 |
148 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37397123 |
149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36983832 |
150 | Platelet activation_Homo sapiens_hsa04611 | 0.36637582 |
151 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36286393 |
152 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35613000 |
153 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35342207 |
154 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34763424 |
155 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34655447 |
156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33172156 |
157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32988486 |
158 | Amoebiasis_Homo sapiens_hsa05146 | 0.32692117 |
159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27806834 |
160 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27350277 |
161 | RNA polymerase_Homo sapiens_hsa03020 | 0.27040300 |
162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26680156 |
163 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26397667 |
164 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25409628 |
165 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24102328 |
166 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23983016 |
167 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23389000 |